Literature DB >> 12109659

Very-high-flow injection rate for upper abdominal CT angiography.

Masashi Kimura1, Yasukazu Shioyama, Toshiyuki Okumura, Kouji Yamada, Michihisa Kawashima, Hiroki Minamiguti, Takami Hagihira, Kazushi Kishi, Morio Sato.   

Abstract

BACKGROUND: The purpose of this study was to compare a very-high-flow injection-rate method (group A) and a conventional injection-rate method (group B) for visualization of upper abdominal arteries by multidetector helical computed tomography (MDHCT).
METHODS: The subjects were 240 patients suspected to have abdominal lesions. They were randomly assigned to group A (120 patients) and group B (120 patients). In group A, the bilateral medial cubital veins were punctured, and contrast medium was infused at a rate of 8.6-9.6 ml/s. In group B, the unilateral medial cubital vein was punctured, and contrast medium was infused at a rate of 2.0-3.0 ml/s. The quality of vascular visualization was graded as poor, good, or excellent by three radiologists.
RESULTS: All visualizations of the celiac trunk (CE) and superior mesenteric artery (SMA) were graded as excellent in both group A and group B. Visualization grades of the subsegmental branches of the hepatic artery (HA), right gastric artery (RGA), cystic artery, dorsal pancreatic artery (DPA), and superior pancreaticoduodenal artery (SPDA) were good or excellent, in 75% (paging method)/53.3% (three-dimensional method), 85%/30%, 77.7%/18.3%, 76.7%/28.3%, and 88.3%/42.5%, respectively, in group A, and 33.3%/11.7%, 46.7%/3.4%, 41.6%/5%, 55%/4.2%, and 72.5%/14.2%, respectively, in group B. The appearance rate of intrahepatic portal branches was 28.3% in group A and 66.7% in group B in the arterial dominant phase.
CONCLUSION: Group A showed better visualization results than Group B in upper abdominal arteries according to MDHCT.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12109659     DOI: 10.1007/bf02990111

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  8 in total

1.  Pancreatic CT imaging: effects of different injection rates and doses of contrast material.

Authors:  T Kim; T Murakami; S Takahashi; A Okada; M Hori; Y Narumi; H Nakamura
Journal:  Radiology       Date:  1999-07       Impact factor: 11.105

2.  [Computed tomography of the abdomen with multidetector-array CT].

Authors:  U J Schoepf; C Becker; R Brüning; C Hong; G F Rust; T Helmberger; P Leimeister; A Stadie; M Niethammer; B Klingemann; M F Reiser
Journal:  Radiologe       Date:  1999-08       Impact factor: 0.635

Review 3.  Vascular anatomy of the pancreaticoduodenal region: A review.

Authors:  G Murakami; K Hirata; T Takamuro; M Mukaiya; F Hata; S Kitagawa
Journal:  J Hepatobiliary Pancreat Surg       Date:  1999

4.  A comparison of two injection protocols using helical and dynamic acquisitions in CT examinations of the pancreas.

Authors:  V M Bonaldi; P M Bret; M Atri; P Garcia; C Reinhold
Journal:  AJR Am J Roentgenol       Date:  1996-07       Impact factor: 3.959

5.  Helical CT anatomy of pancreatic arteries.

Authors:  J S Sim; B I Choi; J K Han; M J Chung; J W Chung; J H Park; M C Han
Journal:  Abdom Imaging       Date:  1996 Nov-Dec

6.  Quantitative evaluation of pancreatic enhancement during dual-phase helical CT.

Authors:  M D Hollett; M J Jorgensen; R B Jeffrey
Journal:  Radiology       Date:  1995-05       Impact factor: 11.105

Review 7.  Helical (spiral) CT of the abdomen.

Authors:  R K Zeman; S H Fox; P M Silverman; W J Davros; L M Carter; D Griego; D I Weltman; S M Ascher; C J Cooper
Journal:  AJR Am J Roentgenol       Date:  1993-04       Impact factor: 3.959

8.  Pancreatic arterial anatomy: depiction with dual-phase helical CT.

Authors:  M Chong; P C Freeny; U P Schmiedl
Journal:  Radiology       Date:  1998-08       Impact factor: 11.105

  8 in total
  1 in total

1.  [Multidetector computed tomography of the liver].

Authors:  W Schima; C Kulinna; A Ba-Ssalamah; T Grünberger
Journal:  Radiologe       Date:  2005-01       Impact factor: 0.635

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.